LEO 43204 - Formula 2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LEO 43204 - Formula 2, covering 2019-02-27 to 2019-02-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis [Phase 1, Phase 2]